Fenbufen

Fenbufen

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	M01AE05 (WHO)
Legal status
Legal status	POM
Identifiers
IUPAC name 4-(4-Biphenylyl)-4-oxobutanoic acid or 4-Oxo-4-(4-phenylphenyl)butanoic acid
CAS Number	36330-85-5
PubChem (CID)	3335
DrugBank	DB08981 Y
ChemSpider	3218 Y
UNII	9815R1WR9B Y
KEGG	D01344 Y
ChEBI	CHEBI:31599 Y
ChEMBL	CHEMBL277522 Y
ECHA InfoCard	100.048.148
Chemical and physical data
Formula	C16H14O3
Molar mass	254.2854
3D model (Jmol)	Interactive image
SMILES O=C(O)CCC(=O)c2ccc(c1ccccc1)cc2
InChI InChI=1S/C16H14O3/c17-15(10-11-16(18)19)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2,(H,18,19) Y Key:ZPAKPRAICRBAOD-UHFFFAOYSA-N Y
(verify)

Fenbufen is a non-steroidal anti-inflammatory drug in the propionic acid derivatives class.^[1]

It was introduced by American Cyanamid under the trade name Lederfen in the 1980s and was withdrawn from markets in the developed world due to liver toxicity in 2010.^{[2][3]:370, 383-384}

As of 2015 it was available in Taiwan and Thailand under several brand names.^[4]

References